Cell cycle profiles and expressions of p21CIP1 AND P27KIP1 during myocyte development

R A Poolman1, R Gilchrist, G Brooks

  • 1Cardiovascular Cellular and Molecular Biology Laboratory, The Rayne Institute, St. Thomas' Hospital, London, United Kingdom.

Insights

Cardiac myocytes stop dividing after birth, preventing heart regeneration. Researchers found that p21CIP1 and p27KIP1 (cyclin-dependent kinase inhibitors) increase with development, blocking cell division and potentially offering therapeutic targets for heart repair.

Area of Science:

  • Cardiovascular Biology
  • Cell Cycle Regulation
  • Molecular Cardiology

Background:

  • Cardiac myocytes lose the ability to divide shortly after birth.
  • This limits the heart's capacity for regeneration following injury, such as myocardial infarction.
  • Understanding the molecular mechanisms that halt myocyte division is crucial for developing regenerative therapies.

Purpose of the Study:

  • To investigate the cell cycle profile of rat ventricular myocytes during development.
  • To determine the expression and activity of cyclin-dependent kinase inhibitors (CDKIs), specifically p21CIP1 and p27KIP1.
  • To elucidate the role of these CDKIs in the cessation of myocyte proliferation.

Main Methods:

  • Fluorescent activated cell sorting (FACS) was used to analyze the cell cycle phases (G0/G1, S, G2/M) of myocytes.
  • Western blotting or similar techniques were likely used to assess protein expression levels of p21CIP1 and p27KIP1.
  • In vitro kinase assays were performed to measure CDK2 activity in myocyte extracts, with and without immunodepletion of CDKIs.

Main Results:

  • FACS analysis revealed a significant decrease in S-phase myocytes and a concomitant increase in G0/G1 and G2/M phase cells during development.
  • The expression of both p21CIP1 and p27KIP1 significantly increased throughout cardiac development.
  • Adult myocyte extracts markedly reduced neonatal myocyte CDK2 kinase activity, an effect reversed by p21CIP1 immunodepletion.

Conclusions:

  • p21CIP1 and p27KIP1 play a significant role in the withdrawal of cardiac myocytes from the cell cycle.
  • These CDKIs are likely responsible for maintaining the G0/G1 and G2/M phase blockades in mature cardiomyocytes.
  • Targeting these molecules could offer novel therapeutic strategies for promoting cardiac regeneration.

Related Concept Videos

Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Molecular Factors Affecting Cell Division01:27

Molecular Factors Affecting Cell Division

Several external and internal factors influence the initiation and inhibition of cell division. For instance, the death of nearby cells or the release of human growth hormone (hGH) promotes cell division. In contrast, lack of hGH or crowding of cells can inhibit cell division.
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...